ADVERTISEMENT

Clinical Summary

Newer glucose-lowering drugs may reduce chronic obstructive pulmonary disease exacerbations

Miriam Tucker   |   11 November 2022

Takeaway

  • In a large population-based study, both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) were associated with lower risk for severe COPD exacerbations among people with both type 2 diabetes and COPD compared with sulphonylureas.
  • Dipeptidyl peptidase-4 inhibitors (DPP4is) had a minimal effect.

Why this matters

  • Laboratory findings suggest that the...

          

November Challenge

Ends in 1d 6h
left
right

Topic Challenges

left
right